Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Shinkai

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|March 21, 2007
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancerShigeki Umemura, Yoshihiko Segawa, Hiroshi Ueoka, et al.
Japanese Journal of Clinical Oncology|November 20, 2010
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome, Ken Yamaguchi, Noriharu Shijubo, et al.
Japanese Journal of Clinical Oncology|November 8, 2014
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†Hiroko Tsukada, Akira Yokoyama, Koichi Goto, et al.
Cancer|September 13, 2006
Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancerYoshihiko Segawa, Katsuyuki Hotta, Shigeki Umemura, et al.
Cancer Chemotherapy and Pharmacology|March 30, 2007
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancerMasahiro Tabata, Katsuyuki Kiura, Niro Okimoto, et al.
Japanese Journal of Radiology|July 28, 2012
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatmentYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Japanese Journal of Clinical Oncology|April 25, 2008
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patientsKazuhiko Nakagawa, Koichi Yamazaki, Hideo Kunitoh, et al.
Japanese Journal of Radiology|March 28, 2012
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumorsYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II studyYuichi Takiguchi, Takashi Seto, Yukito Ichinose, et al.
Japanese Journal of Clinical Oncology|October 15, 2009
Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancerYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|March 21, 2007
Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancerShigeki Umemura, Yoshihiko Segawa, Hiroshi Ueoka, et al.
Japanese Journal of Clinical Oncology|November 20, 2010
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome, Ken Yamaguchi, Noriharu Shijubo, et al.
Japanese Journal of Clinical Oncology|November 8, 2014
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†Hiroko Tsukada, Akira Yokoyama, Koichi Goto, et al.
Cancer|September 13, 2006
Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancerYoshihiko Segawa, Katsuyuki Hotta, Shigeki Umemura, et al.
Cancer Chemotherapy and Pharmacology|March 30, 2007
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancerMasahiro Tabata, Katsuyuki Kiura, Niro Okimoto, et al.
Japanese Journal of Radiology|July 28, 2012
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatmentYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Japanese Journal of Clinical Oncology|April 25, 2008
Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I/II study in Japanese patientsKazuhiko Nakagawa, Koichi Yamazaki, Hideo Kunitoh, et al.
Japanese Journal of Radiology|March 28, 2012
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumorsYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II studyYuichi Takiguchi, Takashi Seto, Yukito Ichinose, et al.
Japanese Journal of Clinical Oncology|October 15, 2009
Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancerYasushi Hamamoto, Masaaki Kataoka, Motohiro Yamashita, et al.
Pageof 5